Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

(1995): Shinohara K, NEnglJMed333, 1222
(1994): Akiyama Y+, Jpn J Dermatol (Japanese) 104, 436
(1994): Tone T+, Jpn J Dermatol 104, 1047
(1993): Christian B+, Presse Med (French) 22, 783
(1993): Mihara K+, Miyazakiikaishi (Japanese) 17, 40
(1993): Nagai A+, Int J Hematol 58, 129
(1993): Oeda E+, Am J Hematol 44, 213
(1992): Orlow SJ+, Arch Dermatol 128, 566
(1991): Cnudde F+, Int J Dermatol 30, 147
(1989): Rasokat H+, Dtsch Med Wochenschr (German) 114, 158
Injection-site pruritus
(1989): Detmar U+, Contact Dermatitis 20, 149
Injection-site reactions
(2000): Stafford-Fox V+, Clin J Oncol Nurs 4(4), 164
Injection-site vasculitis
(1997): Christian MM+, JAmAcadDermatol37, 118
Myalgia/Myositis/Myopathy/Myotoxicity (71%) [L]; (69%) [K]
(2002): Alpsoy E+, Arch Dermatol 138, 467
(2002): Herrine SK, AnnInternMed136(10), 747
(2001): Karim A+, Am J Med Sci 322(4), 233
(2000): Shenefelt PD+, Arch Dermatol 136, 837
(1999): Spieth K+, Arch Dermatol 135, 1035
(1998): Dippel E+, Arch Dermatol 134, 880 (4 patients)
(1997): Brehler R+, JAmAcadDermatol36, 983 (passim)
(1984): Foon KA+, NEnglJMed19, 1259 (passim)
Nephrotoxicity
(2002): Willson RA, J Clin Gastroenterol 35(1), 89 (with ribavirin)
(2001): Kintzel PE, Drug Saf 24(1), 19
Polyarteritis nodosa
(2001): Drug & Ther Perspect 17, 15
Rhabdomyolysis
(2003): Gabrielli M+, Am J Gastroenterol 98(4), 940
(2001): van Londen GJ+, J Clin Oncol 19(17), 3794
(1995): Anderlini P+, Cancer 76, 678
Vogt–Koyanagi–Harada disease
(2003): Sylvestre DL+, JViralHepat10(6), 467 (with ribavirin)
INTERFERON BETA
Synonyms: rIFN-b; IFNB-1b; IFN-beta1b
Trade names: Avonex (Biogen); Betaseron (Berlex); Rebif
(Merck)
Indications: Relapsing multiple sclerosis, cancers
Category: Immunomodulator; Interferon
Half-life: 10 hours
Reactions
Skin
Abscess
Adverse effects (sic)
(1999): Rice GP+, Neurology 52(9), 1893
(1998): Rio J+, Neurologia 13(9), 422
Allergic granulomatous angiitis (Churg–Strauss syndrome)
(1998): Mehta CL+, JAmAcadDermatol39(6), 1024
Allergic reactions (sic)
(1998): Cohen BA+, Allergy Asthma Proc 19(2), 85
(1997): Elgart GW+, JAmAcadDermatol37(4), 553
(1996): Neilley LK+, Neurology 46(2), 552
Basal cell carcinoma (